🟢 Inovio Pharmaceuticals is trading 6% up in pre-market with no clear catalyst identified

Inovio Pharmaceuticals is trading at $1.16, up 5.98%, with no clear company-specific catalyst identified in available October 9, 2026 news.

• The latest company information located was prior coverage of lead candidate INO-3107 and the FDA’s October 30 decision date; it does not establish a reason for the pre-market move.
• The supplied market context is mixed and does not clearly explain the rise.
• Pre-market volume information was not available.